Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 September 2022 | Story Gerda-Marié van Rooyen | Photo Supplied
Lisa Msiza
Lisa Nondumiso Msiza is the first Deaf person from the UFS to receive the prestigious Abe Bailey travel bursary.

Lisa Nondumiso Msiza is the first Deaf person from the UFS to receive the prestigious Abe Bailey Travel Bursary. This second-year student in Linguistics and Sign Language will visit the UK for three weeks, starting late November. Charity Morrison of the Centre for Universal Access and Disability Support (CUADS) will accompany her to interpret for her.

“I want to show through action that Deaf people can do anything. We have the required skills; we can read and write too – just like hearing people can. I would also like to make people aware that the UFS has the facilities to accommodate Deaf people,” says Lisa. Currently, 12 Deaf students are enrolled at this tertiary institution. 

This born Johannesburger’s passion for teaching and facilitating Sign Language is contagious. “I want to observe different businesses and programmes in the UK in order to learn how to start projects and develop myself and my community as Deaf people get limited opportunities. I want to teach people on the use, culture and history of Sign Language.” 

Lisa describes herself as a kind, understanding, and loving person. As she was born deaf, Sign Language is her home language. Her parents, however, are Zulu and Ndebele speaking. She says that, although Sign Language is different in every language, she quickly adapts and communicates in it as soon as she grasps the structure of the new language.

Being named top achiever (learner) for the 2020 matric class and being crowned in fifth position at the World Deaf Model 2021, Lisa is proof that beauty and brains can co-exist. 

“I am passionate about being a teacher, facilitator, or lecturer. I enjoy teaching others sign language so we can communicate more effectively. I love Sign Language and I am always trying to inform people on the importance of learning about Deaf people and to help others understand the nature of language and communication.” 

Her future dreams include becoming a lecturer at the UFS or to continue her studies abroad, but only to gain insight and benefit her community. “I want our country to prosper and would like to have every news bulletin interpreted for the Deaf.”

News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept